A new study published in the Journal of American Medical Association showed that psoriasis patients who used antibiotics had ...

Sino Biopharmaceutical ( ($HK:1177) ) has provided an update. Sino Biopharmaceutical has reported positive Phase II clinical trial results for ...

In the second half of his Maui Derm recap, George Martin, MD, founder and program director of the meeting, highlights new ...

Complete clearance lasts for a very long time due to knockout of resident memory T cells within the skin,’ said the study’s ...

Among patients with psoriasis who have active or recent cancer, biologic therapies show similar cancer progression or recurrence and serious infection rates compared with conventional systemic agents.

Psoriasis on a woman’s skin. Psoriasis is a condition in which skin cells are produced much faster than normal. The body cannot shed the cells fast enough, resulting in patches (plaques) of scaly, ...

Following COVID-19–related lockdown measures, preferences for the use of biologics among Japanese patients with psoriasis addressed administration route, visits, and risk of serious infections ...

Medically reviewed by Casey Gallagher, MD Key Takeaways Clobex spray is a powerful corticosteroid that can clear psoriasis ...

Plaque psoriasis is characterized by the formation of distinct erythematous scaly patches with clear boundaries. 1 The disease results from dysregulation of the innate and adaptive immune systems and ...

Gradient-boosted decision trees and logistic regression were effective in identifying the optimal biologic therapy for psoriasis patients, according to a study. Researchers conducted a ...

DAKOTA DUNES | A woman sits in her hair stylist's chair and brushes her long auburn locks back to reveal red, scaly patches on her neck. Embarrassed, she visits her doctor and is prescribed Humira.

Patients with moderate to severe psoriasis treated with methotrexate (MTX) plus tumor necrosis factor (TNF), interleukin (IL)-17 inhibitors, or IL-23 inhibitors experienced a comparable risk of ...